Background Immune mechanisms are indicated in schizophrenia (SCZ). Recent genome-
wide association studies (GWAS) have identified genetic variants associated with SCZ and …

Converging evidence implicates immune abnormalities in schizophrenia (SCZ), and recent
genome-wide association studies (GWAS) have identified immune-related single-nucleotide …

There has been intense debate over the immunological basis of schizophrenia, and the
potential utility of adjunct immunotherapies. The major histocompatibility complex is …

Background Complex immune-brain interactions that affect neural development, survival
and function might have causal and therapeutic implications for psychiatric illnesses …

Background Positive associations between the risk of schizophrenia and the level of white
blood cells (WBC) count have been suggested by observational studies. However, the …

Background Schizophrenia patients and their parents have an increased risk of immune
disorders compared to population controls and their parents. This may be explained by …

Schizophrenia is a severe psychiatric disorder of complex etiology. Immune processes have
long been proposed to contribute to the development of schizophrenia, and accumulating …

Many immune diseases occur at different rates among people with schizophrenia compared
to the general population. Here, we evaluated whether this phenomenon might be explained …

Genome-wide association studies (GWAS) and proteomic studies have provided convincing
evidence implicating alterations in immune/inflammatory processes in schizophrenia …

Common genetic variants identified in genome-wide association studies (GWAS) show
varying degrees of genetic pleiotropy across complex human disorders. Clinical studies of …